DBV Technologies (DBVT) News Today → America’s worst nightmare? (From Porter & Company) (Ad) Free DBVT Stock Alerts $0.58 +0.04 (+7.44%) (As of 12:50 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 14 at 3:52 AM | americanbankingnews.comDBV Technologies (NASDAQ:DBVT) Earns Hold Rating from Analysts at StockNews.comMay 13 at 2:40 AM | americanbankingnews.comHC Wainwright Comments on DBV Technologies S.A.'s Q2 2024 Earnings (NASDAQ:DBVT)May 10, 2024 | americanbankingnews.comDBV Technologies (NASDAQ:DBVT) Price Target Cut to $5.00May 9, 2024 | finanznachrichten.deDBV Technologies S.A.: DBV Technologies to Participate in Upcoming Investor ConferencesMay 9, 2024 | globenewswire.comDBV Technologies to Participate in Upcoming Investor ConferencesMay 8, 2024 | markets.businessinsider.comOptimistic Buy Rating for DBV Technologies with Viaskin’s Market Potential and Regulatory ProspectsMay 8, 2024 | marketbeat.comHC Wainwright Trims DBV Technologies (NASDAQ:DBVT) Target Price to $5.00HC Wainwright cut their price objective on DBV Technologies from $10.00 to $5.00 and set a "buy" rating on the stock in a research report on Wednesday.May 8, 2024 | markets.businessinsider.comBuy Rating Affirmed for DBV Technologies SA Amidst Strong Clinical Progress and Solid Financial FootingMay 8, 2024 | finance.yahoo.comDBV Technologies Reports Q1 2024 Financial Results Amidst Progress and ChallengesMay 8, 2024 | investorplace.comDBVT Stock Earnings: DBV Technologies Beats EPS, Misses Revenue for Q1 2024May 7, 2024 | finanznachrichten.deDBV Technologies S.A.: DBV Technologies Reports First Quarter 2024 Financial Results and Business UpdateMay 7, 2024 | marketwatch.comDBV Technologies Posts Wider 1Q Loss, Reports Going Concern DoubtsMay 7, 2024 | globenewswire.comDBV Technologies Reports First Quarter 2024 Financial Results and Business UpdateMay 6, 2024 | americanbankingnews.comStockNews.com Begins Coverage on DBV Technologies (NASDAQ:DBVT)April 25, 2024 | globenewswire.comCombined General Meeting of May 16, 2024April 4, 2024 | finance.yahoo.comInformation regarding the total number of voting rights and total number of shares of the Company as of March 31, 2024April 1, 2024 | marketbeat.comDBV Technologies S.A. (NASDAQ:DBVT) Short Interest UpdateDBV Technologies S.A. (NASDAQ:DBVT - Get Free Report) saw a significant drop in short interest during the month of March. As of March 15th, there was short interest totalling 548,100 shares, a drop of 6.2% from the February 29th total of 584,500 shares. Based on an average daily trading volume, of 67,900 shares, the short-interest ratio is currently 8.1 days.March 20, 2024 | seekingalpha.comDBVT DBV Technologies S.A.March 19, 2024 | marketbeat.comShort Interest in DBV Technologies S.A. (NASDAQ:DBVT) Rises By 9.1%DBV Technologies S.A. (NASDAQ:DBVT - Get Free Report) saw a large increase in short interest in the month of February. As of February 29th, there was short interest totalling 584,500 shares, an increase of 9.1% from the February 14th total of 535,800 shares. Based on an average daily volume of 151,400 shares, the days-to-cover ratio is presently 3.9 days.March 15, 2024 | wsj.comDBV Technologies S.A. ADRMarch 8, 2024 | markets.businessinsider.comBuy Rating Affirmed for DBV Technologies on Viaskin Patch Development and Positive Trial OutcomesMarch 8, 2024 | finance.yahoo.comDBV Technologies S.A. (NASDAQ:DBVT) Q4 2023 Earnings Call TranscriptMarch 8, 2024 | marketbeat.comDBV Technologies (NASDAQ:DBVT) Announces Earnings Results, Beats Estimates By $0.10 EPSDBV Technologies (NASDAQ:DBVT - Get Free Report) posted its earnings results on Thursday. The company reported ($0.06) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.16) by $0.10. The company had revenue of $8.88 million during the quarter, compared to analysts' expectations of $1.10 million. During the same period in the previous year, the company posted ($0.23) EPS.March 8, 2024 | finanznachrichten.deDBV Technologies S.A.: DBV Technologies announces filing of 2023 Annual Report on Form 10-K and Universal Registration DocumentMarch 8, 2024 | globenewswire.comDBV Technologies announces filing of 2023 Annual Report on Form 10-K and Universal Registration DocumentMarch 7, 2024 | finance.yahoo.comDBV Technologies SA Reports Decrease in Net Loss and Advances Clinical Programs in Full Year ...March 7, 2024 | msn.comDBVT Stock Earnings: DBV Technologies Beats EPS, Beats Revenue for Q4 2023March 7, 2024 | globenewswire.comDBV Technologies Reports Full Year 2023 Financial Results and Business UpdateMarch 5, 2024 | marketbeat.comDBV Technologies (DBVT) Scheduled to Post Earnings on ThursdayDBV Technologies (NASDAQ:DBVT) will be releasing earnings after the market closes on Thursday, March 7, Zacks reports.March 4, 2024 | globenewswire.comDBV Technologies to Report Full Year 2023 Financial Results and Business Update on March 7, 2024February 26, 2024 | markets.businessinsider.comBuy Rating Affirmed for DBV Technologies on Strong Viaskin Peanut Patch Clinical Data and Promising TrialsFebruary 24, 2024 | msn.comDBV Technologies S.A. - Depositary Receipt () (DBVT) Price Target Increased by 15.78% to 2.62February 21, 2024 | marketbeat.comDBV Technologies (NASDAQ:DBVT) Stock Rating Reaffirmed by HC WainwrightHC Wainwright restated a "buy" rating and issued a $10.00 target price on shares of DBV Technologies in a report on Wednesday.February 20, 2024 | finanznachrichten.deDBV Technologies S.A.: DBV Technologies to Participate in Upcoming AAAAI 2024 CongressFebruary 20, 2024 | finance.yahoo.comDBV Technologies to Participate in Upcoming AAAAI 2024 CongressFebruary 20, 2024 | globenewswire.comDBV Technologies to Participate in Upcoming AAAAI 2024 CongressFebruary 20, 2024 | marketbeat.comDBV Technologies (NASDAQ:DBVT) Share Price Crosses Below Fifty Day Moving Average of $0.89DBV Technologies (NASDAQ:DBVT) Stock Crosses Below 50-Day Moving Average of $0.89February 13, 2024 | msn.comEuropean Equities Traded in the US as American Depositary Receipts Fall in Tuesday TradingFebruary 9, 2024 | msn.comDBV Technologies And 2 Other Stocks Under $2 Insiders Are BuyingFebruary 1, 2024 | marketbeat.comDBV Technologies (NASDAQ:DBVT) Stock Crosses Above Fifty Day Moving Average of $0.86DBV Technologies (NASDAQ:DBVT) Share Price Passes Above Fifty Day Moving Average of $0.86January 22, 2024 | finance.yahoo.comHalf-Year Report on the DBV Technologies Liquidity Contract with ODDO BHFJanuary 9, 2024 | msn.comEuropean Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday TradingJanuary 4, 2024 | msn.comEuropean Equities Traded in the US as American Depositary Receipts Rise in Thursday TradingDecember 28, 2023 | marketbeat.comDBV Technologies S.A. (NASDAQ:DBVT) Sees Significant Growth in Short InterestDBV Technologies S.A. (NASDAQ:DBVT - Get Free Report) was the target of a large growth in short interest in December. As of December 15th, there was short interest totalling 798,700 shares, a growth of 274.4% from the November 30th total of 213,300 shares. Based on an average daily trading volume, of 411,800 shares, the short-interest ratio is presently 1.9 days.December 13, 2023 | marketbeat.comDBV Technologies S.A. (NASDAQ:DBVT) Sees Large Decline in Short InterestDBV Technologies S.A. (NASDAQ:DBVT - Get Free Report) saw a large drop in short interest in the month of November. As of November 30th, there was short interest totalling 213,300 shares, a drop of 39.7% from the November 15th total of 354,000 shares. Based on an average daily trading volume, of 347,800 shares, the short-interest ratio is currently 0.6 days.December 4, 2023 | finance.yahoo.comInformation regarding the total number of voting rights and total number of shares of the Company as of November 30, 2023November 27, 2023 | msn.comDown -25.23% in 4 Weeks, Here's Why You Should You Buy the Dip in DBV Technologies S.A. (DBVT)November 22, 2023 | benzinga.comChief Executive Officer at DBV Technologies Acquires Company Stock Options Worth 806,672 SharesNovember 13, 2023 | markets.businessinsider.comPositive EPITOPE Trial Results Bolster Viaskin’s Potential: DBV Technologies SA Receives Buy RatingNovember 9, 2023 | markets.businessinsider.comDBV Technologies Announces 2-Year Results from Ongoing Phase 3 Open-Label Extension to the EPITOPE Trial (EPOPEX) of Viaskin™ Peanut in Toddlers Get DBV Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for DBVT and its competitors with MarketBeat's FREE daily newsletter. Email Address Biden to Drop BOMBSHELL June 13th? (Ad)Biden’s days are numbered! According to a former CIA and Pentagon insider… He’s about to drop out of the presidential race on June 13th! Click here now to see his shocking evidence. DBVT Media Mentions By Week DBVT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DBVT News Sentiment▼0.380.57▲Average Medical News Sentiment DBVT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DBVT Articles This Week▼181▲DBVT Articles Average Week Get DBV Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for DBVT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Vaxart News Molecular Partners News Cardiol Therapeutics News Vigil Neuroscience News Omega Therapeutics News aTyr Pharma News Scilex News Sangamo Therapeutics News bluebird bio News Cardiff Oncology News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DBVT) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperInvest Now: Starpax's Cancer Breakthrough Achieving What Others Haven't for a CenturyStarpaxHUGE BUY ALERT: Move Fast, Musk...Stansberry ResearchDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DBV Technologies S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
